Middle East & Africa Sterile Injectable Contract Manufacturing Market Size & Outlook
Related Markets
MEA sterile injectable contract manufacturing market highlights
- The MEA sterile injectable contract manufacturing market generated a revenue of USD 818.0 million in 2025.
- The market is expected to grow at a CAGR of 8.9% from 2026 to 2033.
- In terms of segment, small molecule was the largest revenue generating molecule type in 2025.
- Large Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.
- Country-wise, Turkey is expected to register the highest CAGR from 2026 to 2033.
MEA data book summary
| Market revenue in 2025 | USD 818.0 million |
| Market revenue in 2033 | USD 1,605.5 million |
| Growth rate | 8.9% (CAGR from 2026 to 2033) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | Baxter International Inc, Catalent Inc, Recipharm, Fresenius SE & Co KGaA, Cipla Ltd DR, Vetter Pharma-Fertigung, Aenova Group, Unither Pharmaceuticals, Famar, Sorrento Therapeutics Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.3% of the global sterile injectable contract manufacturing market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 16,692.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sterile Injectable Contract Manufacturing Market Scope
Sterile Injectable Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Famar | View profile | 1001-5000 | Athens, Attiki, Greece, Europe | https://www.famar-group.com |
| Aenova Group | View profile | 5001-10000 | Greensboro, North Carolina, United States, North America | http://www.aenova-group.com |
| Unither Pharmaceuticals | View profile | 1001-5000 | Paris, Ile-de-France, France, Europe | https://www.unither-pharma.com/ |
| Vetter Pharma-Fertigung | View profile | 5001-10000 | Ravensburg, Baden-Wurttemberg, Germany, Europe | https://www.vetter-pharma.com/en |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Sorrento Therapeutics Inc | View profile | 949 | 4955 Directors Place, San Diego, CA, United States, 92121 | https://www.sorrentotherapeutics.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Middle East & Africa sterile injectable contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sterile injectable contract manufacturing market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 75.07% in 2025. Horizon Databook has segmented the Middle East & Africa sterile injectable contract manufacturing market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Middle East & Africa sterile injectable contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa sterile injectable contract manufacturing market databook
-
Our clientele includes a mix of sterile injectable contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa sterile injectable contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa sterile injectable contract manufacturing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
MEA sterile injectable contract manufacturing market size, by country, 2021-2033 (US$M)
Middle East & Africa Sterile Injectable Contract Manufacturing Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
